Streetbeat News

Regulatory

MSFT

TSM

UAE President Sheikh Mohamed bin Zayed al-Nahyan is visiting the US to discuss AI cooperation with President Joe Biden. The UAE aims to secure US support for its AI ambitions, reduce fossil fuel dependence, and establish a framework for AI collaboration. The UAE has partnered with Nvidia and announced a $30 billion AI fund with BlackRock, Global Infrastructure Partners, and Microsoft. Additionally, TSM and Samsung are considering building chip megafactories in the UAE.

Portfolio Pulse from Benzinga Neuro

September 23, 2024 | 12:58 pm

OTRK

The trading halt status was updated at 8:55:00 AM ET, indicating a quotation resumption. This update may involve OTRK, suggesting potential news or developments related to the company.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:55 pm

VTGN

Vistagen has initiated the PALISADE-4 Phase 3 study for Fasedienol, aimed at treating social anxiety disorder. This marks a significant step in the development of their treatment pipeline.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:32 pm

TOVX

Theriva Biologics has successfully reached its target patient enrollment for the VIRAGE Phase 2b trial of VCN-01 in combination with Gemcitabine/Nab-Paclitaxel for treating metastatic pancreatic cancer. The trial is being conducted across 15 sites in Spain and the USA.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:26 pm

LTRN

Lantern Pharma has received three FDA Rare Pediatric Disease Designations for its drug LP-184, targeting malignant rhabdoid tumors, rhabdomyosarcoma, and hepatoblastoma. This brings the total to four RPDDs for the company.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:19 pm

SPRC

SciSparc shares rose following FDA approval to start a Phase IIb clinical trial for SCI-110, targeting Tourette syndrome.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:18 pm

SPRC

SciSparc has received FDA approval to begin a Phase IIb clinical trial for its drug SCI-110, aimed at treating Tourette Syndrome. This marks a significant step forward in the company's drug development process.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:18 pm

SNY

Sanofi's Sarclisa has received FDA approval for use as a first-line treatment for newly diagnosed multiple myeloma patients not eligible for stem cell transplants. This marks Sarclisa's third US approval and highlights its effectiveness in reducing disease progression.

Portfolio Pulse from Vandana Singh

September 23, 2024 | 12:16 pm

KMB

Schneider Electric and Kimberly-Clark have announced new Tax Credit Transfer (TCT) agreements to support grid resiliency and clean energy transition in the U.S. These agreements, facilitated by Schneider Electric, involve funding for four battery energy storage projects by Kimberly-Clark, leveraging the Inflation Reduction Act's tax credit transferability. The projects aim to advance renewable energy storage and generation, particularly in Texas.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:14 pm

SPY

Minneapolis Fed President Kashkari emphasized the strength of the labor market and expressed a desire to maintain it. He also stated that he won't declare victory over inflation yet.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:13 pm